VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Dec 09, 2024 1:23pm

40 Views

Post# 36353052

ASCEND is making in the cardiac nuclear medicine world

Revolutionizing Cardiac Nuclear Medicine: From Disconnection to Integration ASCEND Cardiovascular 9 dcembre 2024

https://www.linkedin.com/pulse/revolutionizing-cardiac-nuclear-medicine-from-disconnection-aelyc/?trackingId=K%2B6VfyoMtLR%2B8WKUSR%2FSzg%3D%3D

With heart disease being a leading cause of mortality, any delays or inefficiencies can directly impact patient outcomes. Cardiac nuclear medicine offers critical value in managing heart disease by providing precise, non-invasive imaging that helps assess blood flow, detect blockages, and evaluate heart function.

Check out this article to learn more about the advancements ASCEND is making in the cardiac nuclear medicine world: